Sector Healthcare Value A USD |
Performance History | 31/03/2024 |
Growth of 1,000 (EUR) |
Fund | 0.2 | 19.6 | 4.9 | -1.8 | 6.4 | |
+/-Cat | -11.0 | 3.0 | 14.6 | -1.0 | -0.2 | |
+/-Idx | - | -6.4 | 4.7 | -1.6 | -3.1 | |
Category: Sector Equity Healthcare | ||||||
Benchmarks: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 19/04/2024 | USD 515.92 | |
Day Change | 0.64% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00B40JDW74 | |
Fund Size (Mil) 19/04/2024 | USD 412.80 | |
Share Class Size (Mil) 19/04/2024 | USD 9.64 | |
Max Initial Charge | - | |
Ongoing Charge 03/02/2023 | 1.25% |
Investment Objective: Sector Healthcare Value A USD |
The investment process behind Sector Healthcare Value Fund is based on a fundamentally driven model for bottom up stock valuation within the global Healthcare and Biotech sector. The portfolio will contain 20-40 long positions. Value creation and valuation: Valuation is the single most important factor in the investment team's model. Several valuation models are used, and they based on an in-house view on normalised earnings, future growth/returns and the duration of the growth. Momentum and sentiment: The investment team also considers more short term factors which can modify their long-term fundamental view. The investment team may also take risk on these factors unless the company is significantly overvalued. Portfolio construction: the investment manager considers the degree of mis-pricing given by the scorecard model relative to the total risk of the individual security expressed through the security's history and options' implied volatility. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Trond Horneland 16/11/2010 | ||
Inception Date 16/11/2010 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Sector Healthcare Value A USD | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
GSK PLC | Healthcare | 6.91 |
Medtronic PLC | Healthcare | 6.05 |
Pfizer Inc | Healthcare | 5.80 |
Roche Holding AG | Healthcare | 5.55 |
Sanofi SA | Healthcare | 4.81 |
Increase Decrease New since last portfolio | ||
Sector Healthcare Value A USD |